Qritive Joins Forces with Roche to Redefine Global Cancer Diagnostics with AI

Qritive Pte. Ltd. Denmark Finland Germany Netherlands Sweden United Kingdom

or contact [e-mail].

About Qritive:

Headquartered in Singapore, with operations in the US and India, Qritive is a breakthrough Artificial Intelligence (AI) solution developer that is advancing digital pathology for cancer diagnosis and improving health outcomes. Qritive leverages deep learning technology to support the interpretation of pathology tests for time and resource-strapped pathologists, enabling faster diagnosis and reducing time to treatment for patients. Qritive is dedicated to empowering healthcare professionals across the globe with AI-powered solutions to operate collaboratively at the peak of their performance despite complexity and distance.

Photo - https://mma.prnewswire.com/media/2502765/Image.jpg
Logo - https://mma.prnewswire.com/media/2502766/Qritive_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/qritive-joins-forces-with-roche-to-redefine-global-cancer-diagnostics-with-ai-302245489.html